Characteristics of oedema formation induced by N-formyl-methionyl-leucyl-phenylalanine in rabbit skin

British Journal of Pharmacology
P G HellewellT J Williams

Abstract

1. The characteristics of N-formyl-methionyl-leucyl-phenylalanine (FMLP)-induced oedema formation were investigated in vivo in rabbit skin. 2. FMLP injected intradermally alone induced a small increase in plasma leakage, but marked synergism with prostaglandin E2 (PGE2) in producing oedema responses was observed. In the presence of PGE2, FMLP was equiactive with C5a des Arg and 100-1000 times more active than histamine in terms of permeability-increasing activity. The response to FMLP was not dependent on endogenous histamine release. 3. FMLP-induced responses were of long duration (t1/2 approximately 40-50 min) when compared with bradykinin (t1/2 approximately 4-5 min). 4. The activity of a range of N-formyl peptides in increasing vascular permeability in skin correlated well with their activity as neutrophil stimulants in vitro. 5. Intravenous infusion of zymosan-activated plasma (ZAP) resulted in transient neutropenia and inhibition of oedema formation induced by FMLP and C5a des Arg in the skin. Responses to bradykinin were unaffected by the infusion of ZAP. 6. Intravenous injection of the non-steroidal antiinflammatory drug, ibuprofen, resulted in an inhibition of FMLP-induced, but not histamine-induced, oedema formation. ...Continue Reading

References

Dec 8, 1977·Nature·T J Williams, M J Peck
May 1, 1978·Mutation Research·M Sawada, M Ishidate
Mar 1, 1975·Proceedings of the National Academy of Sciences of the United States of America·E SchiffmannS M Wahl
May 1, 1989·British Journal of Pharmacology·P G Hellewell, T J Williams
Nov 1, 1985·Proceedings of the National Academy of Sciences of the United States of America·S AbramsonG Weissmann
Feb 1, 1987·Immunopharmacology·V G Nielsen, R O Webster
Jan 1, 1982·The Journal of Experimental Medicine·H Carp
Apr 15, 1983·Biochemical Pharmacology·P M SimmonsS Moncada
Feb 1, 1982·British Journal of Pharmacology·F M Cunningham, M J Smith
Oct 1, 1984·Journal of Pharmaceutical Sciences·E G MaderazoC L Woronick
Aug 1, 1983·British Journal of Pharmacology·G A HiggsK Seager
Feb 1, 1981·Canadian Journal of Physiology and Pharmacology·C K ChaplerM A Lillie

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alternative Complement Pathway

The Alternative Complement Pathway is part of the innate immune system, and activation generates membrane attack complexes that kill pathogenic cells. Discover the latest research on the Alternative Complement Pathway.